Amicus Therapeutics CEO John Crowley
from Talks at GS Hosted by Goldman Sachs
In this episode of Talks at GS, John F. Crowley, chairman and CEO of Amicus Therapeutics discusses his leadership at Amicus Therapeutics, his efforts to develop cutting-edge treatments for rare diseases and disorders, and his perspective as a biotech innovator on the global response to the pandemic.
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of Talks at GS?
This episode is 30 minutes long.
When was this Talks at GS episode published?
This episode was published on June 4, 2021.
Can I download this Talks at GS episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.